Table 2.
Change in MSHQ-EjD and IIEF at the start and after treatment in men with benign prostatic hyperplasia (n = 326).
| Groups |
Group A (N = 107) |
Group B (N = 107) |
Group C (N = 112) |
|||
|---|---|---|---|---|---|---|
| Observation period | Before treatment | After treatment | Before treatment | After treatment | Before treatment | After treatment |
| MSHQ-EjD (in scores) | ||||||
| Overall rating | 67.9 (12.4) | 91.5 (10.4)∗ | 72.4 (14.5) | 102.6 (16.9)∗ | 76.6 (16.3) | 109.6 (15.6)∗ |
| Erectile domain | 13.9 (2.9) | 16.5 (3.1) | 12.7 (3.4) | 14.6 (2.5) | 14.0 (4.1) | 16.3 (1.5) |
| Ejaculation | 19.6 (3.1) | 25.4 (2.1)∗ | 18.2 (2.2) | 24.4 (1.5)∗ | 17.4 (2.5) | 25.3 (2.3)∗ |
| Satisfaction | 34.4 (4.1) | 49.6 (7.6)∗ | 41.5 (8.9) | 63.6 (9.1)∗ | 45.2 (7.4) | 67.9 (9.4)∗ |
| IIEF questionnaire (in scores) | ||||||
| Overall rating | 47.2 (4.8) | 58.6 (4.0)∗ | 49.6 (6.7) | 65.0 (7.3)∗ | 49.2 (5.7) | 66.3 (5.2)∗ |
| Erectile domain | 24.4 (2.6) | 25.8 (3.7) | 26.2 (3.4) | 26.9 (5.4) | 24.9 (7.3) | 25.7 (5.2) |
| Satisfaction with intercourse | 8.1 (1.3) | 11.6 (1.5)∗ | 6.7 (2.4) | 12.6 (2.7)∗ | 7.8 (2.1) | 14.5 (2.5)∗ |
| Orgasmic function | 5.1 (0.8) | 7.4 (1.5)∗ | 6.0 (1.4) | 8.9 (0.8)∗ | 5.4 (1.4) | 8.8 (1.3)∗ |
| Libido | 4.7 (1.6) | 7.1 (3.2) | 5.1 (0.8) | 7.9 (1.1)∗ | 5.0 (1.4) | 8.2 (1.3) ∗ |
| Overall satisfaction | 4.9 (2.5) | 6.7 (2.8) | 5.6 (0.9) | 8.7 (1.4)∗ | 6.1 (1.2) | 9.1 (1.4)∗ |
IIEF, international index of erectile function; MSHQ-EjD, Men's Sexual Health Questionnaire—ejaculatory dysfunction.
Standard deviation (SD) is indicated in parentheses; significance of differences in the same group before and after treatment is denoted as ∗ (P ≤ 0.05).